Deep Brain Stimulation Market Zooms Towards Billion-Dollar Valuation: Estimated to Reach USD 2.67 Billion by 2030: Factual Market Research

Deep Brain Stimulation (DBS) is a medical treatment involving the implantation of a device to deliver electrical stimulation to specific brain areas. It primarily treats neurological disorders such as Parkinson's disease, essential tremor, and dystonia. The DBS market has witnessed significant growth in recent years due to technological advancements, increasing prevalence of neurological disorders, and rising geriatric population. This report provides an in-depth analysis of the global DBS market, including drivers, challenges, opportunities, regional analysis, and future outlook.

The Global Deep Brain Stimulation Market is projected to grow from $1.16 billion to $2.67 billion, at a CAGR of 9.7% during the forecast period 2021-2030.

𝐑𝐞𝐩𝐨𝐫𝐭 𝐌𝐞𝐭𝐡𝐨𝐝𝐨𝐥𝐨𝐠𝐲:

The data for this report was collected through primary and secondary research methods. Primary research involved interviews with industry experts, key stakeholders, and healthcare professionals. Secondary research included a thorough analysis of industry reports, company websites, government publications, and academic papers on deep brain stimulation and neurological disorders. The data obtained from these sources was analyzed and synthesized to comprehensively and accurately assess the DBS market.

𝐑𝐞𝐪𝐮𝐞𝐬𝐭 𝐚 𝐅𝐫𝐞𝐞 𝐒𝐚𝐦𝐩𝐥𝐞 𝐩𝐝𝐟 𝐫𝐞𝐩𝐨𝐫𝐭: https://www.factualmarketresearch.com/Request-for-sample/12401

𝐌𝐚𝐫𝐤𝐞𝐭 𝐃𝐫𝐢𝐯𝐞𝐫𝐬:

Increasing prevalence of neurological disorders: The growing number of patients suffering from Parkinson's disease, essential tremor, and dystonia is driving the demand for DBS devices as an effective treatment option.

Advancements in technology: Continuous technological advancements in DBS devices, such as smaller, more efficient, and programmable devices, are improving patient outcomes and expanding the market.

Rising geriatric population: As the global population ages, the incidence of neurological disorders is expected to rise, further fueling the demand for DBS devices.

𝐂𝐡𝐚𝐥𝐥𝐞𝐧𝐠𝐞𝐬 𝐚𝐧𝐝 𝐎𝐩𝐩𝐨𝐫𝐭𝐮𝐧𝐢𝐭𝐢𝐞𝐬:

High cost of treatment: The cost of DBS treatment, including the surgical procedure and device, can be a significant barrier for many patients, especially in developing countries.

Risk of complications: DBS surgery carries some risks, including infection, hardware malfunction, and cognitive side effects, which may deter some patients from opting for this treatment.

Regulatory challenges: Stringent regulatory approval processes and reimbursement issues may hinder the market's growth in certain regions.

𝐑𝐞𝐪𝐮𝐞𝐬𝐭 𝐟𝐨𝐫 𝐂𝐮𝐬𝐭𝐨𝐦𝐢𝐳𝐚𝐭𝐢𝐨𝐧: https://www.factualmarketresearch.com/Request-for-customization/12401

𝐒𝐨𝐦𝐞 𝐨𝐟 𝐭𝐡𝐞 𝐩𝐫𝐨𝐦𝐢𝐧𝐞𝐧𝐭 𝐩𝐥𝐚𝐲𝐞𝐫𝐬 𝐩𝐫𝐨𝐟𝐢𝐥𝐞𝐝 𝐢𝐧 𝐭𝐡𝐞 𝐑𝐞𝐩𝐨𝐫𝐭 𝐚𝐫𝐞 𝐚𝐬 𝐟𝐨𝐥𝐥𝐨𝐰𝐬:

Abbott, Medtronic, Boston Scientific Corporation, Aleva Neurotherapeutics S.A., Nexstim, LivaNova PLC, Neuropace Inc.

𝐌𝐚𝐫𝐤𝐞𝐭 𝐒𝐞𝐠𝐦𝐞𝐧𝐭𝐚𝐭𝐢𝐨𝐧:

By Application,

Parkinson's Disease
Epilepsy
Essential Tremor
Dystonia
Obsessive Compulsive Disorder
Others

By End-user,

Hospitals
Ambulatory Surgical Centers
Neurological Clinics
Others

By Region Type,

North America
Europe
Asia-Pacific
LAMEA

𝐏𝐮𝐫𝐜𝐡𝐚𝐬𝐞 𝐭𝐡𝐢𝐬 𝐏𝐫𝐞𝐦𝐢𝐮𝐦 𝐌𝐚𝐫𝐤𝐞𝐭 𝐑𝐞𝐩𝐨𝐫𝐭 𝐚𝐭:
https://www.factualmarketresearch.com/Checkout/12401

𝐑𝐞𝐠𝐢𝐨𝐧𝐚𝐥 𝐀𝐧𝐚𝐥𝐲𝐬𝐢𝐬:

North America: The North American region dominates the DBS market due to well-established healthcare infrastructure, a high prevalence of neurological disorders, and increasing investment in research and development.

Europe: Europe holds a significant share in the market, driven by a rising geriatric population and a growing focus on advanced healthcare technologies.

Asia-Pacific: The Asia-Pacific region is expected to witness substantial growth, attributed to the increasing awareness about DBS treatment, improving healthcare infrastructure, and rising healthcare expenditure.

𝐅𝐮𝐭𝐮𝐫𝐞 𝐎𝐮𝐭𝐥𝐨𝐨𝐤:

The future of the DBS market looks promising with ongoing research and development efforts aimed at improving the efficacy and safety of DBS devices. Miniaturization of devices, integration with artificial intelligence, and personalized treatment approaches are anticipated to enhance the market's growth. Additionally, expanding indications for DBS beyond neurological disorders may open up new opportunities in other medical fields.

The Deep Brain Stimulation market has seen remarkable growth in recent years, driven by increasing prevalence of neurological disorders, technological advancements, and rising geriatric population. However, challenges such as high treatment costs and potential complications need to be addressed to ensure widespread adoption of DBS as a viable treatment option. With continued research and development, the market is expected to witness further expansion, offering hope for improved quality of life for patients suffering from neurological disorders.

𝐂𝐨𝐧𝐭𝐚𝐜𝐭 𝐔𝐬
Factual Market Research
Email id: sales@factualmarketresearch.com
Ph.: US +18007743961 | UK +448081897087 | APAC +919717322206

𝐀𝐛𝐨𝐮𝐭 𝐔𝐬
We at Factual Market Research are always looking for ways to do better. We are committed to offering companies in-depth information that will aid in planning precise and successful growth strategies for our customers.
We are aware of the quantity and quality of the information flowing. We can categorize and rectify the data required for insight through a thorough and synchronized analytical effort. By offering sensitive data collection and analysis on-site, we assume responsibility for providing our respected clients with detailed and exhaustive research and data gathering.

This release was published on openPR.